You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Select search scope: search across all journals or within the current journal

Search this journal

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

All content on this site: Copyright © 2026 Sage Publications. All rights reserved. This website is technically supported and operated by China National Publications Import and Export (Group) Co., Ltd. 京ICP备09090397号-11

Subcutaneous GR43175 in the Treatment of Acute Migraine: An International Study

Cephalalgia

Impact Factor: 4.6 / 5-Year Impact Factor: 5.0

Journal Homepage Submission guidelines

Restricted access

Research article

First published online October, 1989

Subcutaneous GR43175 in the Treatment of Acute Migraine: An International Study

, , [...], and

Volume 9, Issue 10_suppl

https://doi.org/10.1177/0333102489009S10185

Abstract

Get full access to this article

View all access options for this article.

References

1.

Doenicke

A

Brand

J

Perrin

VL

. Possible benefit of GR43175, a novel 5HT1-like receptor agonist, for the acute treatment of severe migraine. Lancet 1988; 1: 1309–11.

2.

Tfelt-Hansen

P.

Early clinical experience with subcutaneous GR43175 in acute migraine. Cephalalgia (1989) 9 (Suppl. 9) (in press).

Browse journal

All articles Browse by year

Similar articles

Free access

Vertigo and Dizziness Related to Migraine: A Diagnostic Challenge

Free access

Prevalence of Migraine and Non-Migrainous Headache—Head-HUNT,A Large Population-Based Study

Free access

Free access

Epidemiology of medication overuse headache in the general Swedish population